https://www.kalqyl.se/uppdatering-absolicon-q2-24/2024-10-01T12:58:20+00:00https://www.kalqyl.se/uppdatering-absolicon-q124/2024-10-01T13:04:26+00:00https://www.kalqyl.se/uppdatering-absolicon-q423/2024-10-01T13:08:33+00:00https://www.kalqyl.se/uppdatering-absolicon-q323/2024-10-01T13:08:40+00:00https://www.kalqyl.se/uppdatering-eql-pharma-q124-25/2024-10-01T13:29:35+00:00https://www.kalqyl.se/uppdatering-eql-pharma-q423-24/2025-02-03T12:11:08+00:00https://www.kalqyl.se/uppdatering-eql-pharma-q223-24/2024-10-01T13:32:28+00:00https://www.kalqyl.se/uppdatering-gullberg-jansson-q224/2024-10-01T13:33:52+00:00https://www.kalqyl.se/uppdatering-gullberg-jansson-q124/2024-10-01T13:34:59+00:00https://www.kalqyl.se/uppdatering-gullberg-jansson-q423/2024-10-01T13:36:07+00:00https://www.kalqyl.se/uppdatering-gullberg-jansson-q323/2024-10-01T13:37:07+00:00https://www.kalqyl.se/uppdatering-mindark-q224/2024-10-01T14:08:26+00:00https://www.kalqyl.se/uppdatering-mindark-q124/2024-10-01T14:10:39+00:00https://www.kalqyl.se/uppdatering-mindark-q423/2024-10-01T14:11:55+00:00https://www.kalqyl.se/uppdatering-mindark-q323/2024-10-01T14:13:02+00:00https://www.kalqyl.se/uppdatering-stayble-therapeutics-q224/2024-10-02T07:19:57+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-avseende-interimsdata/2024-10-02T07:21:40+00:00https://www.kalqyl.se/uppdatering-stayble-therapeutics-q124/2024-10-02T07:22:33+00:00https://www.kalqyl.se/uppdatering-stayble-therapeutics-q423/2024-10-02T07:23:36+00:00https://www.kalqyl.se/uppdatering-adtraction-q224/2024-10-01T13:11:19+00:00https://www.kalqyl.se/uppdatering-adtraction-q124/2024-10-01T13:12:58+00:00https://www.kalqyl.se/uppdatering-adtraction-q423/2024-10-01T13:14:34+00:00https://www.kalqyl.se/uppdatering-adtraction-group-q323/2024-10-01T13:16:06+00:00https://www.kalqyl.se/uppdatering-plejd-q224/2024-10-02T07:05:51+00:00https://www.kalqyl.se/uppdatering-plejd-q124/2024-10-02T07:07:08+00:00https://www.kalqyl.se/uppdatering-plejd-q423/2024-10-02T07:08:02+00:00https://www.kalqyl.se/uppdatering-plejd-q323/2024-10-02T07:09:12+00:00https://www.kalqyl.se/uppdatering-angler-gaming-q224/2024-10-01T13:19:55+00:00https://www.kalqyl.se/uppdatering-angler-gaming-q124/2024-10-01T13:21:06+00:00https://www.kalqyl.se/uppdatering-angler-gaming-q423/2024-10-01T13:22:20+00:00https://www.kalqyl.se/uppdatering-angler-gaming-q323/2024-10-01T13:23:19+00:00https://www.kalqyl.se/uppdatering-infracom-q224/2024-10-01T14:00:27+00:00https://www.kalqyl.se/uppdatering-infracom-q124/2024-10-01T14:02:52+00:00https://www.kalqyl.se/uppdatering-infracom-q423/2024-10-01T14:04:21+00:00https://www.kalqyl.se/uppdatering-infracom-q323/2024-10-01T14:05:57+00:00https://www.kalqyl.se/uppdatering-purefun-q423-24/2024-10-02T07:13:09+00:00https://www.kalqyl.se/uppdatering-purefun-q323-24/2024-10-02T07:14:04+00:00https://www.kalqyl.se/initial-take-purefun-group/2024-10-02T07:15:26+00:00https://www.kalqyl.se/nelly-group-initial-take/2025-07-08T12:04:35+00:00https://www.kalqyl.se/absolicon-vd-intervju-med-joakim-bystrom-avseende-q224/2024-09-25T12:02:56+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-avseende-q224/2024-09-25T12:03:14+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-angaende-q124/2024-09-25T12:03:19+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-angaende-q423/2024-09-25T12:03:26+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-angaende-samarbetet-med-ferghana-partners/2024-09-25T12:03:29+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-angaende-fas-2b-studien-inom-degenerativa-disksjukdomar/2024-09-25T12:03:35+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-angaende-q223/2024-09-24T12:17:26+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-angaende-q123/2024-09-25T12:03:42+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-angaende-foretradesemission/2024-09-24T12:44:08+00:00https://www.kalqyl.se/stayble-therapeutics-intervju-med-vd-andreas-gerward-angaende-q322/2024-09-24T12:46:51+00:00https://www.kalqyl.se/absolicon-vd-intervju-med-joakim-bystrom-angaende-q124/2024-09-24T12:49:17+00:00https://www.kalqyl.se/absolicon-intervju-med-vd-joakim-bystrom-angaende-q423/2024-09-24T12:50:58+00:00https://www.kalqyl.se/absolicon-intervju-med-vd-joakim-bystrom-angaende-q323/2024-09-24T13:22:45+00:00https://www.kalqyl.se/absolicon-intervju-med-vd-joakim-bystrom-angaende-q223/2024-09-24T13:42:12+00:00https://www.kalqyl.se/absolicon-intervju-med-vd-joakim-bystrom-angaende-nyemission/2024-09-24T13:44:16+00:00https://www.kalqyl.se/absolicon-vd-intervju-med-joakim-bystrom-angaende-q422/2024-09-24T13:45:39+00:00https://www.kalqyl.se/absolicon-pm-kommentar-angaende-forsaljning-av-produktionslina/2024-09-24T13:46:57+00:00https://www.kalqyl.se/absolicon-intervju-med-vd-joakim-bystrom-angaende-q322/2024-09-24T13:48:26+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-avseende-q124-25/2024-09-25T07:12:51+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-angaende-q423-24/2024-09-25T07:15:11+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-angaende-q323-24/2024-09-25T07:28:03+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-angaende-q223-24/2024-09-25T07:29:30+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-angaende-q123-24/2024-09-25T07:43:31+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-angaende-de-senaste-utlicensieringsavtalen/2024-09-25T07:45:03+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-angaende-q4-2022-23/2024-09-25T07:46:21+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-angaende-q3-2022-23/2024-09-25T07:48:44+00:00https://www.kalqyl.se/eql-pharma-intervju-med-vd-axel-schorling-angaende-q2-2022-23/2024-09-25T07:50:02+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-angaende-q224/2024-09-25T08:43:29+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-angaende-q124/2024-09-25T08:45:02+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-avseende-q423/2024-09-25T08:46:19+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-avseende-q323/2024-09-25T08:47:17+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-avseende-q223/2024-09-25T08:48:21+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-avseende-q123/2024-09-25T08:49:39+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-angaende-q422/2024-09-25T08:50:57+00:00https://www.kalqyl.se/gullberg-jansson-intervju-med-vd-peter-back-angaende-q322/2024-09-25T08:52:22+00:00https://www.kalqyl.se/acuvi-vd-intervju-med-olof-stranding-angaende-q224/2024-09-25T08:55:04+00:00https://www.kalqyl.se/premium-snacks-bolagspresentation-och-vd-intervju-med-henrik-strinning-avseende-q224/2024-09-25T08:58:48+00:00https://www.kalqyl.se/adtraction-group-vd-intervju-med-simon-gustafson-angaende-q224/2024-09-25T09:02:02+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-avseende-q124/2024-09-25T09:03:24+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-avseende-q423/2024-09-25T09:04:36+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-avseende-forsaljning-av-klara-lan-och-nya-samarbeten/2024-09-25T09:07:40+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-avseende-q323/2024-09-25T09:08:49+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-avseende-q223/2024-09-25T09:09:45+00:00https://www.kalqyl.se/vd-intervju-med-simon-gustafson-avseende-adtraction-plus-och-integrationen-av-adservice/2024-09-25T09:10:52+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-angaende-q224/2024-09-25T09:32:16+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-angaende-q124/2024-09-25T09:33:38+00:00https://www.kalqyl.se/plejd-intervju-med-vd-babak-esfahani-angaende-q423/2024-09-25T09:34:55+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-angaende-q323/2024-09-25T09:36:05+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-angaende-q223/2024-09-25T09:37:21+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-angaende-ny-produktkategori/2024-09-25T09:38:32+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-angaende-q123/2024-09-25T09:39:23+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-angaende-q422/2024-09-25T09:40:22+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-angaende-q322/2024-09-25T09:41:26+00:00https://www.kalqyl.se/angler-gaming-vd-intervju-med-thomas-kalita-angaende-q224/2024-09-25T09:43:44+00:00https://www.kalqyl.se/angler-gaming-intervju-med-vd-thomas-kalita-angaende-q124/2024-09-25T09:45:09+00:00https://www.kalqyl.se/angler-gaming-intervju-med-vd-thomas-kalita-angaende-q423/2024-09-25T09:46:13+00:00https://www.kalqyl.se/angler-gaming-intervju-med-vd-thomas-kalita-angaende-q323/2024-09-25T09:49:37+00:00https://www.kalqyl.se/angler-gaming-vd-intervju-med-thomas-kalita-angaende-q223/2024-09-25T09:50:49+00:00https://www.kalqyl.se/angler-gaming-vd-intervju-med-thomas-kalita-angaende-q422/2024-09-25T09:51:58+00:00https://www.kalqyl.se/angler-gaming-intervju-med-vd-thomas-kalita-angaende-q322/2024-09-25T09:53:02+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-angaende-q224/2024-09-25T10:09:26+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-angaende-q124/2024-09-25T10:10:38+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-angaende-forvarvet-av-qsi-sweden/2024-09-25T10:12:13+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-angaende-q423/2024-09-25T10:13:17+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-angaende-q323/2024-09-25T10:14:33+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-angaende-forvarvet-av-comcenter/2024-09-25T10:15:36+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-angaende-q223/2024-09-25T10:21:44+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-angaende-q123/2024-09-25T10:29:28+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-kring-forvarven-av-connect-och-datatal/2024-09-25T10:25:20+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-angaende-q422/2024-09-25T10:26:53+00:00https://www.kalqyl.se/infracom-intervju-med-vd-bo-kjellberg-angaende-q322/2024-09-25T10:28:13+00:00https://www.kalqyl.se/wp-content-uploads-2024-09-igaming-en-guide-for-dig-som-vill-lara-dig-mer_0-1-pdf/2024-09-26T12:58:13+00:00https://www.kalqyl.se/premium-snacks-nordic-initial-take/2024-10-02T07:11:31+00:00https://www.kalqyl.se/uppdatering-purefun-q124-25/2024-12-18T13:41:17+00:00https://www.kalqyl.se/clean-motion-write-up/2024-10-16T09:47:16+00:00https://www.kalqyl.se/adtraction-group-rapportkommentar-q324/2024-12-18T14:45:58+00:00https://www.kalqyl.se/uppdatering-plejd-q324/2024-12-18T13:34:30+00:00https://www.kalqyl.se/uppdatering-eql-pharma-q224-25/2024-12-18T14:45:45+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-angaende-q324/2024-12-18T13:42:18+00:00https://www.kalqyl.se/uppdatering-gullberg-jansson-q324/2024-12-18T14:45:19+00:00https://www.kalqyl.se/uppdatering-absolicon-q324/2024-12-18T13:58:57+00:00https://www.kalqyl.se/uppdatering-premium-snacks-q324/2024-12-18T13:58:13+00:00https://www.kalqyl.se/acuvi-initial-take/2025-02-26T14:02:51+00:00https://www.kalqyl.se/infracom-rapportkommentar-q324/2024-12-18T14:02:23+00:00https://www.kalqyl.se/uppdatering-angler-gaming-q324/2024-12-18T14:06:31+00:00https://www.kalqyl.se/uppdatering-stayble-therapeutics-q324/2024-12-18T14:44:45+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-avseende-q324/2025-02-18T07:00:54+00:00https://www.kalqyl.se/absolicon-vd-intervju-med-joakim-bystrom-avseende-q324/2024-12-18T14:13:21+00:00https://www.kalqyl.se/premium-snacks-vd-intervju-med-henrik-strinning-avseende-q324/2025-02-08T22:41:36+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-avseende-q324/2025-01-20T13:12:53+00:00https://www.kalqyl.se/acuvi-vd-intervju-med-olof-stranding-avseende-q324/2025-02-18T07:03:21+00:00https://www.kalqyl.se/angler-gaming-vd-intervju-med-thomas-kalita-avseende-q324/2024-12-18T14:20:26+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-avseende-q2-2425/2025-02-18T06:58:46+00:00https://www.kalqyl.se/uppdatering-mindark-q324/2024-12-18T14:44:24+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-om-det-positiva-studieresultatet/2025-02-18T07:04:59+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-avseende-q324/2025-02-18T07:05:34+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-avseende-forvarv-av-produktportfolj/2025-02-18T06:59:32+00:00https://www.kalqyl.se/uppdatering-purefun-q224-25/2025-01-20T12:10:59+00:00https://www.kalqyl.se/uppdatering-purefun-q124-25-2/2025-01-20T12:10:36+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-om-partnerskapsprocessen/2025-01-20T13:05:21+00:00https://www.kalqyl.se/diagonal-bio-vd-intervju-med-karin-wehlin-om-bolaget-och-den-pagaende-foretradesemissionen/2025-01-27T14:35:10+00:00https://www.kalqyl.se/nanoecho-vd-intervju-med-linda-persson-om-bolaget-och-foretradesemissionen/2025-01-29T12:02:42+00:00https://www.kalqyl.se/diagonal-bio-snabbanalys/2025-01-30T13:57:35+00:00https://www.kalqyl.se/nanoecho-snabbanalys/2025-02-03T12:04:51+00:00https://www.kalqyl.se/uppdatering-eql-pharma-q323-24/2025-02-03T12:09:46+00:00https://www.kalqyl.se/eql-pharma-rapportkommentar-q324-25/2025-02-07T12:51:37+00:00https://www.kalqyl.se/nanoecho-vd-intervju-med-linda-persson-om-bolaget-och-foretradesemissionen-2/2025-02-08T13:22:17+00:00https://www.kalqyl.se/plejd-rapportkommentar-q424/2025-02-10T07:05:12+00:00https://www.kalqyl.se/premium-snacks-vd-intervju-med-henrik-strinning-avseende-q424/2025-02-10T12:49:29+00:00https://www.kalqyl.se/premium-snacks-rapportkommentar-q424/2025-02-12T08:11:34+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-avseende-q324-25/2025-02-18T07:16:48+00:00https://www.kalqyl.se/gullberg-jansson-rapportkommentar-q424/2025-02-20T12:23:49+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-om-q424/2025-02-20T12:57:06+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-avseende-q424/2025-02-21T12:23:37+00:00https://www.kalqyl.se/angler-gaming-vd-intervju-med-thomas-kalita-avseende-q424/2025-02-24T11:05:55+00:00https://www.kalqyl.se/angler-gaming-rapportkommentar-q424/2025-02-25T14:00:18+00:00https://www.kalqyl.se/infracom-rapportkommentar-q424/2025-02-25T14:00:57+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-om-q424/2025-02-25T16:23:59+00:00https://www.kalqyl.se/adtraction-rapportkommentar-q424/2025-02-25T17:29:22+00:00https://www.kalqyl.se/acuvi-vd-intervju-med-olof-stranding-om-q424/2025-02-26T12:55:18+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-om-q424/2025-02-27T15:18:10+00:00https://www.kalqyl.se/absolicon-vd-intervju-med-joakim-bystrom-avseende-q424/2025-02-28T15:22:39+00:00https://www.kalqyl.se/absolicon-rapportkommentar-q424/2025-02-28T15:46:15+00:00https://www.kalqyl.se/acuvi-rapportkommentar-q424/2025-03-03T06:58:46+00:00https://www.kalqyl.se/stayble-therapeutics-rapportkommentar-q424/2025-03-04T15:18:41+00:00https://www.kalqyl.se/mindark-rapportkommentar-q424/2025-03-06T09:11:44+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-om-de-nya-finansiella-malen/2025-03-14T16:59:40+00:00https://www.kalqyl.se/lifeclean-intervju-med-ragnar-krefting-om-ramavtalet-i-kina-pa-288-msek/2025-03-24T14:22:34+00:00https://www.kalqyl.se/purefun-rapportkommentar-q324-25/2025-03-27T10:32:41+00:00https://www.kalqyl.se/hoi-publishing-vd-intervju-med-lars-rambe/2025-04-02T13:05:12+00:00https://www.kalqyl.se/lifeclean-snabbanalys/2025-04-08T13:12:54+00:00https://www.kalqyl.se/igrene-vd-intervju-med-annette-berkhahn-blyhammar-om-framtiden/2025-04-10T12:36:35+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-avseende-q125/2025-04-11T11:24:09+00:00https://www.kalqyl.se/plejd-rapportkommentar-q125/2025-07-08T11:53:54+00:00https://www.kalqyl.se/sleep-cycle-initial-take/2025-07-08T12:04:56+00:00https://www.kalqyl.se/sleep-cycle-rapportkommentar-q324/2025-07-08T12:05:12+00:00https://www.kalqyl.se/acuvi-vd-intervju-med-olof-stranding-om-q125/2025-04-25T15:06:21+00:00https://www.kalqyl.se/acuvi-rapportkommentar-q125/2025-04-28T05:27:27+00:00https://www.kalqyl.se/premium-snacks-presentation-och-vd-intervju-med-henrik-strinning-avseende-q125/2025-04-30T13:32:14+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-om-q125/2025-04-30T15:18:31+00:00https://www.kalqyl.se/adtraction-rapportkommentar-q125/2025-05-02T14:33:07+00:00https://www.kalqyl.se/premium-snacks-rapportkommentar-q125/2025-05-12T08:09:55+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-avseende-q125/2025-05-09T13:40:26+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-om-q424-25/2025-05-09T15:24:36+00:00https://www.kalqyl.se/infracom-rapportkommentar-q125/2025-05-12T21:35:34+00:00https://www.kalqyl.se/eql-pharma-rapportkommentar-q424-25/2025-05-12T13:06:48+00:00https://www.kalqyl.se/angler-gaming-vd-intervju-med-thomas-kalita-om-q125/2025-05-16T12:13:51+00:00https://www.kalqyl.se/angler-gaming-rapportkommentar-q125/2025-05-19T09:35:33+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-om-q125/2025-05-19T12:51:30+00:00https://www.kalqyl.se/gullberg-jansson-rapportkommentar-q125/2025-05-19T13:27:09+00:00https://www.kalqyl.se/absolicon-vd-intervju-med-joakim-bystrom-om-q125/2025-05-23T11:49:26+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-om-den-fortsatta-partnerskapsprocessen/2025-05-26T06:04:49+00:00https://www.kalqyl.se/stayble-therapeutics-rapportkommentar-q125/2025-05-26T06:42:02+00:00https://www.kalqyl.se/absolicon-rapportkommentar-q125/2025-05-26T09:25:50+00:00https://www.kalqyl.se/mindark-rapportkommentar-q125/2025-05-30T12:41:52+00:00https://www.kalqyl.se/proport-invest-snabbanalys/2025-06-02T06:47:29+00:00https://www.kalqyl.se/acenta-group-vd-intervju-med-hakan-tollefsen-om-q125/2025-09-08T12:48:19+00:00https://www.kalqyl.se/bitcoin-treasury-capital-vd-intervju-med-christoffer-de-geer-om-emissionen-och-borsnoteringen/2025-06-05T06:56:45+00:00https://www.kalqyl.se/diagonal-bio-vd-intervju-med-karin-wehlin-om-kommersialiseringsprocessen/2025-06-11T09:22:38+00:00https://www.kalqyl.se/homemaid-vd-intervju-med-stefan-hogkvist-om-q125/2025-10-01T13:21:39+00:00https://www.kalqyl.se/acuvi-vd-intervju-med-olof-stranding-om-de-senaste-nyckelhandelserna/2025-06-17T06:04:05+00:00https://www.kalqyl.se/vuxen-group-rapportkommentar-q424-25/2025-07-01T13:51:00+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-avseende-q225/2025-07-11T13:19:11+00:00https://www.kalqyl.se/plejd-rapportkommentar-q225/2025-07-14T06:53:31+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-om-q225/2025-07-25T15:32:23+00:00https://www.kalqyl.se/adtraction-rapportkommentar-q225/2025-07-30T06:40:45+00:00https://www.kalqyl.se/mresell-ai-plattform-och-skalfordelar-driver-lonsam-tillvaxt/2025-09-08T13:14:31+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-om-q125-26/2025-08-11T15:40:56+00:00https://www.kalqyl.se/eql-pharma-rapportkommentar-q125-26/2025-08-13T08:11:41+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-om-q225/2025-08-18T14:10:03+00:00https://www.kalqyl.se/gullberg-jansson-rapportkommentar-q225/2025-08-18T14:38:53+00:00https://www.kalqyl.se/premium-snacks-kvartalspresentation-och-vd-intervju-med-henrik-strinning-om-q225/2025-08-22T14:00:45+00:00https://www.kalqyl.se/acuvi-vd-intervju-med-olof-stranding-om-q225/2025-08-22T15:43:54+00:00https://www.kalqyl.se/angler-gaming-vd-intervju-med-thomas-kalita-avseende-q225/2025-08-25T11:03:57+00:00https://www.kalqyl.se/angler-gaming-rapportkommentar-q225/2025-08-25T12:06:43+00:00https://www.kalqyl.se/acuvi-rapportkommentar-q225/2025-08-25T14:29:19+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-avseende-q225/2025-08-26T13:16:26+00:00https://www.kalqyl.se/premium-snacks-rapportkommentar-q225/2025-08-27T08:24:57+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-om-q225/2025-08-27T14:43:45+00:00https://www.kalqyl.se/stayble-therapeutics-rapportkommentar-q225/2025-08-29T06:14:06+00:00https://www.kalqyl.se/homemaid-vd-intervju-med-stefan-hogkvist-om-q225/2025-10-01T13:21:12+00:00https://www.kalqyl.se/absolicon-rapportkommentar-q225/2025-09-01T13:05:42+00:00https://www.kalqyl.se/mindark-rapportkommentar-q225/2025-09-02T06:51:58+00:00https://www.kalqyl.se/mresell-vd-intervju-med-patrik-la-placa-christiansen-avseende-q225/2025-09-04T07:37:40+00:00https://www.kalqyl.se/mresell-rapportkommentar-q225/2026-02-11T12:54:36+00:00https://www.kalqyl.se/acenta-group-exekverar-pa-den-svenska-overetableringen/2025-09-09T10:16:47+00:00https://www.kalqyl.se/acenta-group-executing-on-the-swedish-overestablishment/2025-09-09T10:15:50+00:00https://www.kalqyl.se/b-treasury-capital/2025-09-16T10:27:32+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-om-de-senaste-leveransforseningarna/2025-09-24T12:06:13+00:00https://www.kalqyl.se/vuxen-group-rapportkommentar-q125-26/2025-09-26T14:08:26+00:00https://www.kalqyl.se/homemaid-tillvaxt-och-stabila-marginaler-med-roll-up-potential/2025-10-02T05:54:04+00:00https://www.kalqyl.se/envar-fran-outsourcing-till-eget-spelslapp/2025-10-12T14:19:24+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-om-q325/2025-10-16T14:11:13+00:00https://www.kalqyl.se/plejd-rapportkommentar-q325/2025-10-17T12:00:28+00:00https://www.kalqyl.se/lumito-vd-intervju-med-sanna-wallenborg-om-bolaget-och-den-pagaende-foretradesemissionen/2025-10-20T10:27:46+00:00https://www.kalqyl.se/qbim-vd-intervju-med-niklas-forsberg-om-bolaget-infor-borsnoteringen/2026-01-14T10:10:07+00:00https://www.kalqyl.se/lumito-tar-nasta-steg-i-kommersialiseringsfasen/2025-10-23T05:57:06+00:00https://www.kalqyl.se/upsales-technology-strategiskt-skifte-med-betydande-tillvaxtpotential/2025-10-27T11:48:27+00:00https://www.kalqyl.se/upsales-technology-vd-intervju-med-daniel-wikberg-om-bolaget-och-q325/2026-02-20T10:57:02+00:00https://www.kalqyl.se/acenta-group-vd-intervju-med-hakan-tollefsen-om-de-senaste-nyckelhandelserna/2026-03-03T11:21:25+00:00https://www.kalqyl.se/acuvi-rapportkommentar-q325/2025-10-31T06:16:38+00:00https://www.kalqyl.se/acuvi-vd-intervju-med-nils-sjoholm-om-hans-bakgrund-och-vagen-framat/2025-10-31T06:41:04+00:00https://www.kalqyl.se/b-treasury-capital-ab-rapportkommentar-q325/2026-01-14T10:11:48+00:00https://www.kalqyl.se/premium-snacks-kvartalspresentation-och-qa-i-samband-med-q325/2025-11-05T13:48:22+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-om-q225-26/2025-11-06T11:43:10+00:00https://www.kalqyl.se/qbim-vd-intervju-med-niklas-forsberg-om-q325/2026-01-14T10:10:29+00:00https://www.kalqyl.se/premium-snacks-rapportkommentar-q325/2025-11-07T15:31:46+00:00https://www.kalqyl.se/adtraction-rapportkommentar-q325/2025-11-10T06:19:41+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-om-q325/2025-11-10T06:42:14+00:00https://www.kalqyl.se/qbim-rapportkommentar-q325/2026-01-14T10:10:05+00:00https://www.kalqyl.se/eql-pharma-rapportkommentar-q225-26/2025-11-12T06:31:58+00:00https://www.kalqyl.se/angler-gaming-vd-intervju-med-thomas-kalita-avseende-q325/2025-11-13T11:25:50+00:00https://www.kalqyl.se/envar-vd-intervju-med-atey-ghailan-avseende-q325/2025-11-14T09:22:16+00:00https://www.kalqyl.se/gullberg-jansson-vd-intervju-med-peter-back-om-q325/2025-11-14T10:56:32+00:00https://www.kalqyl.se/gullberg-jansson-rapportkommentar-q325/2025-11-14T11:05:35+00:00https://www.kalqyl.se/envar-rapportkommentar-q325/2025-11-14T13:28:27+00:00https://www.kalqyl.se/angler-gaming-rapportkommentar-q325/2026-02-18T13:22:40+00:00https://www.kalqyl.se/online-brands-nordic-kvartalspresentation-och-qa-i-samband-med-q325/2025-11-20T15:11:23+00:00https://www.kalqyl.se/homemaid-rapportkommentar-q325/2025-11-21T07:10:35+00:00https://www.kalqyl.se/homemaid-vd-intervju-med-stefan-hogkvist-om-q325/2025-11-21T07:23:33+00:00https://www.kalqyl.se/dellia-group-vd-intervju-med-jan-eriksen-om-q325/2025-11-24T11:38:39+00:00https://www.kalqyl.se/stayble-therapeutics-rapportkommentar-q325/2025-11-25T10:32:40+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-om-q325/2025-11-25T10:57:59+00:00https://www.kalqyl.se/beyond-frames-ett-nytt-kapitel-ar-upplast/2026-01-14T09:54:10+00:00https://www.kalqyl.se/absolicon-vd-intervju-med-joakim-bystrom-om-q325/2025-11-28T13:44:22+00:00https://www.kalqyl.se/mindark-rapportkommentar-q325/2025-12-01T12:44:46+00:00https://www.kalqyl.se/mresell-rapportkommentar-q325/2025-12-01T14:18:05+00:00https://www.kalqyl.se/mresell-vd-intervju-med-patrik-christiansen-avseende-q3/2025-12-01T14:20:45+00:00https://www.kalqyl.se/beyond-frames-interview-with-ceo-ace-st-germain-about-the-company-and-its-upcoming-pipeline/2026-01-14T09:48:44+00:00https://www.kalqyl.se/absolicon-rapportkommentar-q325/2025-12-04T12:56:14+00:00https://www.kalqyl.se/online-brands-fran-nordiska-nischvarumarken-till-internationella-tillvaxtplattformar/2025-12-12T07:20:03+00:00https://www.kalqyl.se/vuxen-group-rapportkommentar-q225-26/2025-12-19T15:33:34+00:00https://www.kalqyl.se/qbim-snabbanalys/2026-01-14T10:43:18+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-om-q425/2026-01-22T16:33:03+00:00https://www.kalqyl.se/plejd-rapportkommentar-q425/2026-01-26T10:07:45+00:00https://www.kalqyl.se/sektorrapport-e-handel/2026-03-17T08:41:01+00:00https://www.kalqyl.se/dellia-first-mover-med-kvalitet-och-smak-i-fokus/2026-01-29T11:27:52+00:00https://www.kalqyl.se/eql-pharma-vd-intervju-med-axel-schorling-om-q325-26/2026-02-05T12:55:50+00:00https://www.kalqyl.se/eql-pharma-rapportkommentar-q325-26/2026-02-06T15:12:43+00:00https://www.kalqyl.se/xer-tech-interview-with-ceo-erik-herlyn-about-the-company-in-connection-with-the-reverse-takeover/2026-02-09T09:09:15+00:00https://www.kalqyl.se/gullberg-jansson-rapportkommentar-q425/2026-02-10T12:57:44+00:00https://www.kalqyl.se/xer-tech-unik-teknik-pa-en-snabbt-vaxande-marknad/2026-02-11T08:33:06+00:00https://www.kalqyl.se/ngm-company-insights-tidig-tillvaxtfas/2026-03-17T08:40:03+00:00https://www.kalqyl.se/ngm-company-insights-tillvaxtbolag/2026-03-17T08:39:41+00:00https://www.kalqyl.se/premium-snacks-presentation-och-vd-intervju-med-henrik-strinning-om-q425/2026-02-13T16:00:45+00:00https://www.kalqyl.se/premium-snacks-rapportkommentar-q425/2026-02-16T07:34:51+00:00https://www.kalqyl.se/envar-vd-intervju-med-atey-ghailan-avseende-q425/2026-02-17T07:30:10+00:00https://www.kalqyl.se/envar-rapportkommentar-q425/2026-02-18T07:35:05+00:00https://www.kalqyl.se/upsales-technology-vd-intervju-med-daniel-wikberg-om-q425/2026-02-20T10:56:40+00:00https://www.kalqyl.se/tribox-group-intervju-med-vd-robert-thoren-och-styrelseordforande-kent-sander-om-bolaget/2026-02-19T06:28:43+00:00https://www.kalqyl.se/upsales-technology-rapportkommentar-q425/2026-02-19T19:00:34+00:00https://www.kalqyl.se/beyond-frames-interview-with-ceo-ace-st-germain-about-q425/2026-03-09T15:33:10+00:00https://www.kalqyl.se/qbim-vd-intervju-med-niklas-forsberg-om-q425/2026-03-09T15:32:54+00:00https://www.kalqyl.se/infracom-vd-intervju-med-bo-kjellberg-avseende-q425/2026-02-20T13:45:41+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-om-q425/2026-02-20T15:02:07+00:00https://www.kalqyl.se/beyond-frames-rapportkommentar-q425/2026-03-03T12:21:20+00:00https://www.kalqyl.se/qbim-rapportkommentar-q425/2026-02-23T07:29:15+00:00https://www.kalqyl.se/adtraction-rapportkommentar-q425/2026-02-23T07:15:58+00:00https://www.kalqyl.se/online-brands-nordic-kvartalspresentation-och-qa-i-samband-med-q425/2026-02-23T21:21:32+00:00https://www.kalqyl.se/angler-gaming-vd-intervju-med-thomas-kalita-avseende-q425/2026-02-23T21:21:44+00:00https://www.kalqyl.se/angler-gaming-rapportkommentar-q425/2026-02-23T14:40:21+00:00https://www.kalqyl.se/homemaid-rapportkommentar-q425/2026-02-25T06:42:57+00:00https://www.kalqyl.se/homemaid-vd-intervju-med-stefan-hogkvist-om-q425/2026-02-25T07:03:55+00:00https://www.kalqyl.se/k-fast-holding-vd-intervju-med-jacob-karlsson-om-q425/2026-02-25T13:25:35+00:00https://www.kalqyl.se/online-brands-nordic-rapportkommentar-q425/2026-02-25T14:18:38+00:00https://www.kalqyl.se/mresell-vd-intervju-med-patrik-christiansen-avseende-q425/2026-02-26T07:40:53+00:00https://www.kalqyl.se/dellia-group-intervju-och-qa-om-q425/2026-02-27T18:35:05+00:00https://www.kalqyl.se/acuvi-vd-intervju-med-nils-sjoholm-om-q425/2026-03-02T07:03:44+00:00https://www.kalqyl.se/mresell-rapportkommentar-q425/2026-03-02T12:19:19+00:00https://www.kalqyl.se/stayble-therapeutics-vd-intervju-med-andreas-gerward-om-q425/2026-03-02T12:15:55+00:00https://www.kalqyl.se/stayble-therapeutics-rapportkommentar-q425/2026-03-02T12:30:23+00:00https://www.kalqyl.se/dellia-rapportkommentar-q425/2026-03-03T10:40:47+00:00https://www.kalqyl.se/acenta-group-vd-intervju-med-hakan-tollefsen-om-q425/2026-03-03T11:20:13+00:00https://www.kalqyl.se/beyond-frames-interview-regarding-the-companys-strategic-adjustment/2026-03-09T15:32:18+00:00https://www.kalqyl.se/acuvi-rapportkommentar-q425/2026-03-04T09:40:55+00:00https://www.kalqyl.se/absolicon-vd-intervju-med-joakim-bystrom-om-q425/2026-03-09T15:31:53+00:00https://www.kalqyl.se/acenta-group-rapportkommentar-q425/2026-03-16T14:55:11+00:00https://www.kalqyl.se/mindark-rapportkommentar-q425/2026-03-04T15:31:11+00:00https://www.kalqyl.se/absolicon-rapportkommentar-q425/2026-03-16T14:54:56+00:00https://www.kalqyl.se/ngm-company-insights-starkta-vinstutsikter/2026-03-18T12:19:14+00:00https://www.kalqyl.se/vuxen-group-rapportkommentar-q325-26/2026-04-01T07:14:38+00:00https://www.kalqyl.se/ngm-company-insights-storsta-bolagen-pa-ngm/2026-04-07T08:38:45+00:00https://www.kalqyl.se/microcap-top-picks-2026/2026-04-15T05:40:24+00:00https://www.kalqyl.se/plejd-vd-intervju-med-babak-esfahani-om-q126/2026-04-10T13:17:55+00:00https://www.kalqyl.se/plejd-rapportkommentar-q126/2026-04-13T13:47:53+00:00https://www.kalqyl.se/upsales-technology-nyhetsuppdatering-gallande-avknoppningen-av-aira/2026-04-14T16:32:22+00:00https://www.kalqyl.se/upsales-technology-vd-intervju-med-daniel-wikberg-om-aira-och-den-foreslagna-avknoppningen/2026-04-15T16:38:09+00:00https://www.kalqyl.se/upsales-technology-rapportkommentar-q126/2026-04-23T11:08:22+00:00https://www.kalqyl.se/adtraction-vd-intervju-med-simon-gustafson-om-q126/2026-04-24T13:21:58+00:00